Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-097202
Filing Date
2013-03-08
Accepted
2013-03-08 07:46:03
Documents
16
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d447762d10k.htm 10-K 1240081
2 EX-10.17 d447762dex1017.htm EX-10.17 9321
3 EX-21.1 d447762dex211.htm EX-21.1 2799
4 EX-23.1 d447762dex231.htm EX-23.1 1704
5 EX-31.1 d447762dex311.htm EX-31.1 6264
6 EX-31.2 d447762dex312.htm EX-31.2 6301
7 EX-32.1 d447762dex321.htm EX-32.1 3518
8 EX-32.2 d447762dex322.htm EX-32.2 3583
15 GRAPHIC g447762g15n63.jpg GRAPHIC 36836
16 GRAPHIC g447762g19e87.jpg GRAPHIC 26102
  Complete submission text file 0001193125-13-097202.txt   6889507

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT drtx-20121231.xml EX-101.INS 931211
10 XBRL TAXONOMY EXTENSION SCHEMA drtx-20121231.xsd EX-101.SCH 74125
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drtx-20121231_cal.xml EX-101.CAL 67709
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drtx-20121231_def.xml EX-101.DEF 345864
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE drtx-20121231_lab.xml EX-101.LAB 498057
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drtx-20121231_pre.xml EX-101.PRE 410052
Mailing Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760
Business Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760 973-993-4867
Durata Therapeutics, Inc. (Filer) CIK: 0001544116 (see all company filings)

EIN.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35599 | Film No.: 13675358
SIC: 2834 Pharmaceutical Preparations